At Torrey Pines Law Group, we specialize in guiding pharmaceutical, medical device and digital health companies through the complex regulatory landscape of the FDA. Our deep understanding of Boston's unique innovation ecosystem provides a foundation to partner with companies seeking to bring cutting-edge technologies to market while ensuring full regulatory compliance.
Boston's medical device and digital health sectors are at the forefront of innovation, supported by:
Our firm has extensive experience navigating the regulatory challenges unique to Boston's thriving ecosystem.
One of the many things that distinguishes Torrey Pines Law Group is our experience and ability to advise on the interaction between patent portfolio development and FDA Regulatory strategy. Our team has substantial experience with all facets of the international FDA regulatory approval and clearance processes for our Boston clients including:
Our strategic consultations employ key knowledge in the area of FDA regulatory, clinical, product design, Quality Compliance, patent strategy, commercialization, and overall development feasibility.
Life sciences, Digital Health, and healthcare fields in which we help our Boston clients include:
Torrey Pines Law Group has a deep understanding of Boston's pharmaceutical, medical device, and digital health landscape. We have a proven track record in FDA regulatory matters and strong relationships with key regulatory bodies. Our expertise with pharmaceuticals, traditional medical devices as well as cutting-edge digital health innovations sets us apart.
If you have a legal issue involving the commercialization and sale of a medical device or drug, we can help you. If you are seeking to clear a medical device or approve a drug in the US Food & Drug Administration (FDA), or in international counterparts such as Europe (EMA), China (NMDA), Japan (PMDA), Health Canada, Australia (TGA), or India (DCGI), we can help you. In addition, if you are developing a reimbursement strategy so that you ensure payment for your medical device, drug, diagnostic, or other regulated product, we are part of a trusted network of specialists who can guide you.
Our regulatory advisors, reimbursement specialists, and network of Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), and business advisors have the experience to help you define multiple paths to market through international regulatory and reimbursement bodies. If you need a Boston FDA regulatory advisor to help you with your international regulatory and reimbursement matters, please contact us for our free consultation to discuss your matter.
COPYRIGHT ©
, TORREY PINES LAW GROUP, PC. ALL RIGHTS RESERVED. | LEGAL NOTICES | SITE MAP | PAYMENTS | STANDARD FIRM CHARGES
Torrey Pines Law Group, PC serves technology innovators with protecting intellectual property, obtaining regulatory approvals and clearances, and making deals and closing technology transactions throughout the U.S., including in major technology hubs such as San Diego, San Francisco, Palo Alto, San Jose, Silicon Valley, Boston, Cambridge, Chicago, Minneapolis, Houston, Dallas, Atlanta, Denver, Seattle, Portland, Boulder, Orlando, the Research Triangle (Raleigh, Durham, and Chapel Hill), the Mid-Atlantic (New Jersey, New York, Philadelphia, Maryland, Virginia, and Washington, DC), Pittsburgh, Cleveland, Ann Arbor, and throughout Southern California in Los Angeles, Orange County, Irvine, Torrey Pines, Sorrento Valley, and La Jolla.
We have experience with international intellectual property, regulatory and transactional matters pending in Beijing, Shanghai, Shenzhen, and Guangzhou China; Tokyo, Japan; Berlin, Munich and Frankfurt Germany; Tel Aviv Israel; Mumbai, Bengaluru, and New Delhi India; London and Edinburgh United Kingdom; Vancouver, Toronto, Calgary and Montreal Canada; Dublin, Ireland; Cape Town, South Africa; Mexico City and Tijuana Mexico; Brussels, Belgium; Copenhagen, Denmark; Paris, France; Madrid and Barcelona Spain; Moscow, Russia; Santiago, Chile; Montevideo, Uruguay; Buenos Aires, Argentina; Sao Paulo and Rio de Janeiro Brazil; Seoul, South Korea; Taipei, Taiwan; Hong Kong; Hanoi, Vietnam; Bangkok, Thailand; Kuala Lumpur, Malaysia; Milan, Italy; Singapore; Sydney, Melbourne, Perth and Adelaide Australia; Auckland, New Zealand; Oslo, Norway; Stockholm, Sweden; Helsinki, Finland; Kiev, Ukraine; Budapest, Hungary; Vienna, Austria; Prague, Czechia; Geneva and Lausanne Switzerland; Bahrain; Doha, Qatar; Abu Dhabi and Dubai UAE; and Jeddah, Saudi Arabia.
Boston FDA regulatory advisors - FDA regulatory law firm - EMA, MHRA, NMDA, PMDA, Health Canada, TGA, DCGI - medical device approvals - medical device clearances - drug approvals - in vitro diagnostics approvals